Chugai Pharmaceutical
(OTC) CHGCY
Chugai Pharmaceutical Financials at a Glance
Market Cap
$90.58B
Revenue (TTM)
$1.32T
Net Income (TTM)
$455.05B
EPS (TTM)
$0.88
P/E Ratio
31.26
Dividend
$0.61
Beta (Volatility)
0.52 (Low)
Dividend
$0.61
Beta (Volatility)
0.52 (Low)
Price
$29.27
Volume
172,075
Open
$27.35
Price
$29.27
Volume
172,075
Open
$27.35
Previous Close
$29.27
Daily Range
$27.35 - $30.25
52-Week Range
$19.50 - $34.84
Dividend
$0.61
Beta (Volatility)
0.52 (Low)
Price
$29.27
Volume
172,075
Open
$27.35
Previous Close
$29.27
Daily Range
$27.35 - $30.25
52-Week Range
$19.50 - $34.84
CHGCY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Chugai Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
7,872
CEO
Osamu Okuda
Website
www.chugai-pharm.co.jpHeadquarters
Tokyo, 103-8324, JP
CHGCY Financials
Key Financial Metrics (TTM)
Gross Margin
71%
Operating Margin
47%
Net Income Margin
35%
Return on Equity
23%
Return on Capital
29%
Return on Assets
18%
Earnings Yield
3.20%
Dividend Yield
0.00%
Payout Ratio
68.99%
Stock Overview
Market Cap
$90.58B
Shares Outstanding
3.29B
Volume
172.07K
Short Interest
0.00%
Avg. Volume
213.38K
Financials (TTM)
Gross Profit
$937.60B
Operating Income
$618.80B
EBITDA
$661.98B
Operating Cash Flow
$408.33B
Capital Expenditure
$79.97B
Free Cash Flow
$328.36B
Cash & ST Invst.
$980.36B
Total Debt
$25.73B
Chugai Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$401.48B
+32.9%
Gross Profit
$298.03B
+43.4%
Gross Margin
74.23%
N/A
Market Cap
$90.58B
N/A
Market Cap/Employee
$18.02M
N/A
Employees
5,026
N/A
Net Income
$147.51B
+61.1%
EBITDA
$208.84B
+35.7%
Quarterly Fundamentals
Net Cash
$954.64B
-3.1%
Accounts Receivable
$443.41B
+32.7%
Inventory
$277.04B
+15.4%
Long Term Debt
$17.95B
+296.1%
Short Term Debt
$7.78B
+22.2%
Return on Assets
17.58%
N/A
Return on Invested Capital
28.68%
N/A
Free Cash Flow
$117.27B
-23.1%
Operating Cash Flow
$135.09B
-11.4%